CBR1 Recombinant Antibody, PE-Cy5.5 Conjugated, PE/Cy5.5, Rabbit

Produktübersicht

• Artikelname: CBR1 Recombinant Antibody, PE-Cy5.5 Conjugated, PE/Cy5.5, Rabbit
• Artikelnummer: BSS-BSM-61367R-PE-CY5.5
• Hersteller Artikelnummer: bsm-61367R-PE-Cy5.5
• Alternativnummer: BSS-BSM-61367R-PE-CY5.5-100
• Hersteller: Bioss
• Wirt: Rabbit
• Kategorie: Antikörper
• Applikation: WB
• Spezies Reaktivität: Human
• Konjugation: PE/Cy5.5
• Alternative Synonym: 15 hydroxyprostaglandin dehydrogenase [NADP+], Carbonyl reductase [NADPH] 1, CBR1, CRN, NADPH dependent carbonyl reductase 1, Prostaglandin 9 ketoreductase, SDR21C1.

Produktbeschreibung

NADPH-dependent reductase with broad substrate specificity. Catalyzes the reduction of a wide variety of carbonyl compounds including quinones, prostaglandins, menadione, plus various xenobiotics. Catalyzes the reduction of the antitumor anthracyclines doxorubicin and daunorubicin to the cardiotoxic compounds doxorubicinol and daunorubicinol.

Produkteigenschaften

• Klonalität: Recombinant
• Konzentration: Lot dependent
• NCBI: 873
• UniProt: P16152
• Puffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
• Quelle: KLH conjugated synthetic peptide derived from human CBR1
• Target-Kategorie: CBR1

Anwendungsbeschreibung

• Application Verdünnung: WB(1:300-5000)